Total Facility Solutions Opens Hygienic Fabrication Center - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Total Facility Solutions Opens Hygienic Fabrication Center


Total Facility Solutions (TFS), a specialty contractor and services company focused on critical process infrastructure, completed the company’s first certified hygienic fabrication facility dedicated to the US life science market. Located in Burlington, North Carolina, the facility will provide hygienic and high-purity piping fabrication, stainless-steel skid fabrication, and field installations.

Off-site fabrication in a controlled environment has the benefits of cost-effectiveness and minimizing the number of people at the construction site area, which makes the site safer, notes the company. “Moving man-hours from a customer site to a regional fabrication facility helps us streamline our work,” said Joe Cestari, TFS president, in the press release. “Reducing congestion in the facility also reduces risk to safety, quality and schedule, all while meeting the stringent hygienic standards of the life science market.”

Source: Total Facility Solutions

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here